PMBN is a polymyxin antibiotic active ingredient used as a pharmaceutical raw material. It is a cyclic peptide with multiple amide and amine groups, characterized by high polarity and a complex ring-containing structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing PMBN?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Polymyxin B2
pharmaceutical raw material
N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]octanamide
research compound
Meldonium dihydrate
pharmaceutical raw material
1-cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
pharmaceutical raw material
Fluralaner
pharmaceutical raw material
Revefenacin
pharmaceutical raw material
Polymyxin B1
pharmaceutical raw material
Polymyxin B1
pharmaceutical raw material
(2S,3R)-2-amino-N-[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]-3-hydroxybutanamide
PYHYGIPVYYRJHU-QWDNBKTCSA-N
C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCN)CCN)CC(C)C)CC2=CC=CC=C2)CCN)NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)N)O
Sourcing PMBN?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.